Access & Innovation

In the village of Gegema, Solomon Islands, health worker takes blood samples for rapid diagnostic tests. © Global Fund / John Rae

In the village of Gegema, Solomon Islands, health worker takes blood samples for rapid diagnostic tests. © Global Fund / John Rae

Timely access to vital malaria commodities can hasten elimination of this disease in the Asia-Pacific. These include diagnostic tools, treatments for drug-resistant malaria, and new tools for controlling mosquito populations.

But several barriers stand in the way. The region needs a better view of the pipeline of innovations and a clearer understanding of how existing and new commodities can support its malaria response. Unless physical and regulatory bottlenecks are eased, adoption of these new tools will be delayed, slowing down the prevention, detection and treatment of new cases.

We cut through today’s cluttered public health landscape, working to fast-track new solutions and unblock the bottlenecks which prevent life-saving solutions from reaching those in need.

APLMA facilitates partnerships to sustain access to new and existing tools to prevent, detect and treat malaria. We also focus on ensuring countries in the region have access to quality medicine and strive to provide universal health coverage.


Footer line